Research and Development

More than 75% of adults living in the UK have now received both doses of the vaccine, as announced by …

Moderna will build a messenger RNA (mRNA) vaccine manufacturing facility in Canada, which will include access to Moderna’s mRNA development …

Kite has announced a positive recommendation from the Scottish Medicines Consortium (SMC) on the company’s Healthcare Technology Assessment for Tecartus, …

An Australian research team has developed a hydrogel that can be used as a one-off intervention to treat Parkinson’s disease, …

Researchers from Cambridge University and The Alan Turing Institute have developed an artificial intelligence (AI) system that can diagnose dementia …

Researchers from Chalmers University of Technology, Sweden, have developed a new method to prevent bacterial infections relating to medical implants …

AstraZeneca has announced the EU approval of Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, alongside a licence extension from …

Under a new agreement announced on Friday, AstraZeneca will licence AZD5153, a potent and selective BRD4 BET inhibitor with a …

A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce COVID infections by …

Japan has warned that COVID-19 cases are surging at an ‘unprecedented pace’, hitting record highs in Tokyo amid the Olympic …

On Wednesday China reported the highest number of new locally transmitted COVID-19 cases since January, with case numbers being driven …

Chilean authorities have released real world data on the varied success of the Sinovac, Pfizer, and AstraZeneca COVID-19 vaccines.Among the …

Eli Lilly and Co plans to seek US approval for its experimental Alzheimer’s drug by the end of the year, …

UK experts are near announcing that all 16 and 17-year-olds should be offered a COVID vaccine in the UK, as …

Novartis has announced that it will launch a new Phase III study to expand the use of Zolgensma – the …